Chondrogenic differentiation of adipose derived stem cells (ASC) is challenging but highly promising for cartilage repair. Large donor variability of chondrogenic differentiation potential raises the risk for transplantation of cells with reduced efficacy and a low chondrogenic potential. Therefore quick potency assays are required in order to control the potency of the isolated cells before cell transplantation. Current in vitro methods to analyze the differentiation capacity are time consuming and thus, a novel enhancer and tissue-specific promoter combination was employed for the detection of chondrogenic differentiation of ASC in a novel quick potency bioassay.
Introduction
Cartilage repair strategies after traumatic injuries range from standard autologous cartilage transplantation (mosaicplasty) or marrow-stimulating techniques (microfracture) up to novel cell based strategies. For the matrix associated chondrocyte transplantation (MACT) 1 , biomaterials are used in combination with expanded human autologous chondrocytes (hAC), a method which originates from a scaffold free procedure, the autologous chondrocyte transplantation (ACT) 2 . One of the biggest drawbacks of cartilage/chondrocyte based methods is that healthy autologous cartilage needs to be harvested from the patient. This creates an additional defect which enhances the risk for developing osteoarthritis. In order to obtain enough cells for treatment it is further necessary to expand chondrocytes in vitro which is accompanied by a dedifferentiation process, leading to fibroblast-like, collagen type I expressing cells 3 . Instead of hAC, mesenchymal stem cells (MSC) may overcome drawbacks accompanied with cartilage harvest and cell expansion.
Bone marrow-derived MSC (BMSC) represent the most intensively investigated MSC type in cartilage tissue engineering. They can be isolated from bone marrow aspirates, expanded in monolayer and induced for chondrogenic differentiation 4, 5 .
Zuk et al. found that adipose-derived stem cells (ASC) also show ability to form cartilage-like matrix, as indicated by Alcian blue and collagen type II staining 6 . In contrast to bone marrow, adipose tissue can be harvested in large amounts by simple surgical procedure. However, a large donor variability for the chondrogenic differentiation potential has been reported 7, 8 , which raises the risk for transplantation of low-potent cells. Therefore, a quick potency assay is required to predict cell potency before transplantation or long-term storage. For assessing the chondrogenic potential collagen type II might be regarded as the most specific and unique marker for hyaline cartilage synthesis. 9 . With our luciferase reporter system we have established a proof of principle concept for the prediction of the chondrogenic differentiation potential within 3 days.
Methods

ASC isolation and cultivation
The collection of human tissue was approved by the local ethical board with patient's consent. Subcutaneous human adipose tissue was obtained during routine outpatient liposuction procedures under local tumescence anaesthesia. Isolation of ASC was performed according to Wolbank et al. 10 . After isolation, cells were cultured in endothelial growth medium (EGM-2; Lonza, Austria) at 37°C, 5% CO 2 , and 95% air humidity to a subconfluent state before passaging. ASC were seeded at a density of 2x10 3 / cm 2 and media was changed every 3-4 days. ASC from passage 1 were used for flow cytometry, histological analysis and reporter experiments. For qRT-PCR experiments cells were expanded up to passage 2-4.
ASC immunophenotype
ASC from passage 1 were characterized by flow cytometry analysis using the Cell Fix™ (BD; diluted 1:10 with aqua dest) and analyzed on a FACSCanto (BD).
Chondrogenic 3D pellet culture
For chondrogenic differentiation and 3D micromass pellet cultures 3x10 5 ASC were centrifuged in chondrogenic differentiation media (hMSC Chondro BulletKit (Lonza) containing 10ng/ml BMP-6 (R&D Systems, Austria) and 10ng/ml TGF-ß3 (Lonza)) in 1.5 mL polypropylene screw cap micro tubes (Sarstedt, Austria). The tubes were placed in an incubator at 37°C, 5% CO 2 , and 95% humidity with slightly open cap for gas exchange. After 2 days the pellets were transferred to 96-well U-bottom plates.
Media was changed every 2-3 days.
Histological analysis
The 3D micromass pellet cultures incubated over 35 days in chondrogenic differentiation media were measured once a week for their cross section area. 
Reporter plasmid
All cloning procedures were carried out using a standard Taq hot-start polymerase (Peqlab Biotechnologie GesmbH, Austria) and the E.coli cloning strain TOP10. The human collagen II alpha 1 promoter (Col2A1 promoter and 5' mRNA UTR from -478 to +179 from the transcriptional start site, see NC_000012.12) was cloned from human genomic DNA isolated from whole blood using the cloning primers hColIIPs 
Statistical Analysis
Data are presented as mean ± standard deviation and statistical analysis was performed using PRISM6 (GraphPad, San Diego, CA, USA). P values of < 0.05 were considered to be significant acquired by parametric 2-way analysis of variance (ANOVA)-Bonferroni post hoc or parametric two-tailed t-test assuming normal distribution according to Kolmogorov-Smirnov normality test. 
Results
Expression of specific ASC surface marker
Definition of donor potential by qRT-PCR, histology and pellet diameter area
Micromass pellets from 9 different donors were analyzed after 35 days of Fig. 2a,b) . Immunohistological stainings showed that donors with low Col2A1 mRNA expression have also low potential to produce collagen type II and sGAGs on protein level, while donors with high Col2A1 expression on mRNA level showed intense staining for Alcian blue and collagen type II (Fig. 3a) . Based on the results of qRT-PCR and histological evaluations we defined donors with high and low differentiation potential, as "good donors" and "bad donors". The pellet diameter area of each good and bad donor was evaluated over time in culture (day 7, 14, 21, 28 and 35) (Fig. 3b) . These results corroborate the immunohistological stainings for Alcian blue and collagen type II.
Donor 2 is in the range of the good donors regarding pellet diameter area but is still negative for Alcian blue and collagen type II staining.. According to the analyses, the threshold for Col2A1 expression on mRNA level was set to 10 and together with the histological and immunohistological data we identified 5 good donors (3, 4, 5, 8, 9) and 4 bad donors (1, 2, 6, 7).
Activation of Col2A luciferase reporter under 3D culture conditions
To visualize transfection efficiency of 3D micromass pellets a GFP plasmid was used (Suppl. Fig. 1a ). The weak fluorescence of un-transfected pellets is probably due to the known autofluorescence of cartilage-like matrix 12 . For the analysis of Col2A
reporter activation micromass pellets of the 9 different donors were transfected with a plasmid containing Metridia luciferase under control of the Col2A promoter together with a plasmid containing Renilla luciferase under control of an ubiquitary promoter.
After 3 days of differentiation the activation of the Col2A luciferase reporter was analyzed and normalized to Renilla luciferase. While there were remarkable differences in the activation of the Col2A reporter (Fig. 4a) , all donors showed similar activation of Renilla luciferase (Fig. 4b) , indicating similar transfection efficiency and promoter activation. These differences in the Col2A reporter activation also occurred after normalization to Renilla activation (Fig. 4c) 4a,c) . Sequential analysis of Col2A reporter activation over the first 3 days of induction showed an increase for both groups, but significantly higher Col2A activation for good donors on day3 (Fig. 4d) . Even after normalization of Col2A activation to Renilla activation the induction of Col2A reporter was significantly stronger in good donors (199 ± 83) compared to bad donors (51 ± 34) (Fig. 4e ).
Col2A1 and Sox9 mRNA expression under 3D culture conditions
As we have observed a luciferase reporter signal only after 3 days of differentiation we performed qRT-PCR for Col2A1 and Sox9. After 3 days Col2A1 expression was not detectable for any donor except minimal levels for donor 2 (Col2A1 mRNA expression of 0.0154) (data not shown). Early marker Sox9 expression after 3 days of differentiation showed also a very low but detectable signal in all donors (Suppl. Fig. 2a ). However no difference between bad and good donors could be discriminated (Suppl. Fig. 2b ).
Activation of Col2A luciferase reporter under 2D culture conditions
In order to simplify the assay we changed from the standard chondrogenic 3D culture conditions to 2D culture conditions, which reduces time and required cell numbers.
Transfection efficiency was analyzed by using a GFP plasmid (Suppl. Fig. 1b) corresponding to 45.3% ± 11.8 of transfected cells as determined by nucleocounting.
ASC were seeded and induced in 2D culture and co-transfected with Col2A reporter plasmid together with Renilla luciferase control plasmid. There was a clear difference in the activation of Col2A reporter between good (6.2x10 5 -1.1x10 6 RLU) and bad donors (2.4x10 5 -7.0x10 5 RLU) found on day 3 of culture ( Fig. 5a ), while Renilla activation was similar in all tested donors (Fig. 5b) (Fig. 5c) , which demonstrates that the potential for chondrogenic differentiation is reflected in Col2A promoter activity at early timepoints even under 2D conditions. Sequential analysis of Col2A reporter activation over the first 3 days
showed an increase for both groups, but again a significantly higher Col2A activation for good versus bad donors on day 3 (Fig. 5d) . Moreover, activation of Col2A reporter was still higher in good donors (25.6 ± 4.3) compared to bad donors (14.2 ± 4.8) after normalization to Renilla activation (Fig. 5e) .
Relation of Col2A luciferase reporter activation to Col2A1 mRNA expression, collagen type II immunostaining or pellet diameter area
For a more clear relation of the 3D micromass pellet data, our day 3 quick potency assay was plotted against qRT-PCR, immunostainings and pellet diameter area of day 35 3D cultures ( Fig.  6) .
By comparing values of Col2A luciferase reporter activation to Col2A1 mRNA expression ( Fig. 6a) as well as to colIagen type II immunostaining intensity (Fig. 6b) the determined good donors 3, 4, 5, 8, 9 and bad donors 1, 2, 6, 7 could clearly be identified. Regarding the relation between Col2A luciferase reporter activation and the pellet diameter area (Fig. 6c) there is no clear cut-off line to identify donor quality, which may however partly be due to the low correlation of pellet size and the quality of chondrogenic differentiation 13, 14 .
Discussion
In the current study we developed a quick potency assay for fast determination of chondrogenic differentiation status of ASC. ASC can be induced for collagen type II expression after extensive passaging 15 , but also directly after isolation from adipose tissue 16 . The expression of collagen type II is mainly regulated via the TGF-ß pathway 17, 18 ; in a previous work we could demonstrate that TGF-β and BMP-6
induce collagen type II expression in ASC, in a 3D culture system 19 promoter-activity could be achieved although Col2A is a late marker and Col2A1 mRNA levels on day 3 were indeed negative. mRNA levels of the early marker Sox9 could be detected in all 9 donors already on day 3. However expression levels were extremely low and did not allow identification of the previously determined donors obtained by Col2A1 mRNA level and immunostainings on day 35. Hence, Sox9 expression on day 3 was not predictive for chondrogenic potency at an early time point. Although 3D micromass pellet culture is the prerequisite for induction of chondrogenic differentiation we simplified this assay and changed to 2D culture.
Surprisingly, also under 2D culture conditions Col2A reporter activity increased over 3 days for all donors with a significant difference on day 3. The change from 3D to 2D contributed towards further improvement by saving time (2 days less, since no pellet formation was necessary) and cell number (1/10) while maintaining the functionality of the assay. Moreover, under 2D conditions no autofluorescence was visible which interferes with the luciferase reporter signal. Considering absolute Metridia (Fig. 4a,   Fig. 5a ) and Renilla (Fig. 4b, Fig. 5b 01.23% ± 0.52 Table 1 Supplemental Table 1 . Immunophenotype of ASC at passage 1. ASC displayed strong expression of mesenchymal stem cell marker CD73, CD90 and CD105 and almost no expression of CD14 (lymphatic), CD34 (endothelial) and CD45
(hematopoietic) which verified the ASC character. The histocompatibility antigen molecule HLA-ABC was expressed at a very high level whereas only a small portion of ASC expressed the histocompatibility antigen class II HLA-DR.
